Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory ...

Reduction observed in RSV-related hospitalizations in adults aged ≥60 years 1 An observed reduction in major adverse ...

Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

Beyfortus is not a vaccine. It’s a monoclonal antibody designed to help protect babies from serious RSV lung infection during ...

Respiratory syncytial virus (RSV) vaccines were an estimated 79% effective against dangerous virus-related blood clots among ...

Adults hospitalized with an acute respiratory syncytial virus (RSV) infection faced an increased risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a ...

Background Respiratory syncytial virus (RSV) causes substantial winter pressure on adult services. In the UK, RSV vaccination ...

Data shows that ER visits and hospital admissions for RSV have been climbing in New Jersey since early October. Currently, ER visits for RSV are “high” or “very high” in more than half of New Jersey ...

Clinicians underutilize RSV testing in adults with respiratory or cardiac exacerbations, potentially obscuring the true burden of disease.

The NHS is expanding free RSV vaccination to over-80s and care home residents, aiming to protect those most at risk of severe illness.

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

Adults hospitalized with a respiratory syncytial virus infection have an increased risk for cardiorespiratory events in the weeks afterward, according to a retrospective analysis.